Background
On lists of major U.S. locations for the life sciences, the greater Philadelphia region is usually at or near the top, giving life sciences companies located here a distinct advantage. At this symposium, a panel of area leaders in the life sciences industry—and winners of the Eastern Technology Council’s 2008 Enterprise Awards—discussed their experiences and insights on a series of questions related to the success of life sciences companies in this region, including:

	What makes Philadelphia attractive for life sciences companies?
	What is the most important factor of your company related to its location in Philadelphia?
	How successful is your company in attracting the best and brightest people to scientific and management positions?
	How does the global economy—particularly the influence of China and India—impact your company?
	What changes has the recent economic downturn imposed upon your company and the industry?

Listen to the program now (streaming audio) Download the full program .zip (97 MB file) Download the full program mp3 (103 MB file)

Panelists

Robert J. Broeze Robert J. Broeze, Ph.D., President and CEO, Laureate Pharma, Inc. Robert J. Broeze has over 20 years of experience in the biopharmaceutical industry. His technical expertise spans research, development, characterization, validation, testing, and cGMP manufacture of biopharmaceutical products, from pilot to phase-III clinical and commercial scale with a strong emphasis on monoclonal antibody products for therapeutic and diagnostic use. Prior to joining Laureate in 1999, Broeze was vice president of biologics research at Purdue BioPharma and vice president of operations at Bard BioPharma. He had previously held positions of increasing responsibility at Cytogen Corporation, with overall responsibility for development and cGMP manufacture of Cytogen's products, and at Collaborative Research, where he held various technical positions. Broeze also worked as a postdoctoral fellow in the Department of Molecular Biophysics and Biochemistry at Yale University, where he studied the molecular biology of the interferon system. He is a graduate of Rensselaer Polytechnic Institute, where he earned both his bachelor’s degree and Ph.D. Listen to the program

Anthony DelConte Anthony DelConte, Chief Medical Officer, Auxilium Pharmaceuticals, Inc. Anthony DelConte is responsible for all clinical development, medical affairs, and safety functions for marketed and investigational products at Auxilium. Prior to joining Auxilium, DelConte was senior vice president of clinical research and development at Genaera Corporation. He had also held various positions in Clinical Development and Medical Affairs at Novartis and at Wyeth Pharmaceuticals. DelConte attended Saint Joseph’s University in Philadelphia and received his medical degree from the University of Pittsburgh. He completed his internship and residency training at Magee-Womens Hospital of the University of Pittsburgh Medical Center. DelConte has served as a full-time faculty member in the Department of Obstetrics and Gynecology at Jefferson Medical College, and he has authored a number of papers and abstracts as well as a chapter in the sixth edition of Glass’ Office Gynecology. He is a fellow of the American College of Obstetricians and Gynecologists and is a diplomat of the American Board of Obstetrics and Gynecology. Listen to the program

Frederick J. Fritz Frederick J. Fritz, Director, President, and CEO, Neuro Diagnostic Devices Frederick J. Fritz leads Neuro Diagnostic Devices (NDD), an early commercial-stage medical device company focused on the neurosurgery market. Fritz joined NDD from Valeo Medical, a biotech company he founded in 2003 to develop the world’s first non-invasive diagnostic test for endometriosis. Fritz began his career in marketing management and new product development. He joined Schering-Plough's Wesley-Jessen in 1985 as vice president of marketing and sales and introduced Durasoft Colors contact lenses in 1986. Fritz was promoted to general manager of Schering-Plough's over-the-counter pharmaceutical business in 1988 and of its podiatric products business in 1990. He then served as president of Coleman North America from 1995 to 1997. In 1997 he founded Songbird Hearing, a medical-device spin-out of Sarnoff Corporation, which developed and launched the world's first disposable hearing aid. Fritz holds an engineering degree from the University of Illinois and an MBA from the Harvard Business School. Listen to the program

Glenn Kenney Glenn Kenney, Vice President of Corporate and Strategy Development, Globus Medical Glenn Kenney is the vice president of corporate and strategy development for Globus Medical, the world’s largest privately-held spinal company focused on the development, manufacture, and distribution of state-of-the-art spine technology products that promote healing in patients with spinal disorders. Kenney is responsible for the following areas within Globus: Surgeon Relations, Basic and Applied Research, Engineering Services, and National Accounts. Prior to joining Globus, Kenney served as president of Teleflex Fluid Systems and led the turnaround of this $130-million division of Teleflex. He had a stellar career in strategic planning, business development, and corporate planning in various multibillion dollar organizations. Kenney began his career serving in the U.S. Navy, first as a lieutenant commander on the nuclear attack submarine U.S.S. Sturgeon, and later in the Office of Naval Intelligence at the Pentagon. He has a bachelor's degree in mechanical engineering from the Georgia Institute of Technology and a master's degree in nuclear engineering from the Naval Nuclear Power School in Orlando. In addition, Kenney has an MBA from the Harvard Business School. Listen to the program

About the Joseph Priestley Society
The Joseph Priestley Society of CHF was founded in 2002 to promote a deeper and more reflective understanding of important scientific, technological, and industry developments. The society has a special orientation to issues involving innovation and entrepreneurship. Members are experienced, senior individuals from a wide variety of large and small chemical companies, and also from the financial, consulting, and academic communities.

Meetings of the Joseph Priestley Society are held the second Thursday of each month from September through April. To register for the next meeting, visit our Calendar of Events.

For more information about the Joseph Priestley Society, please contact Bob Kenworthy, Manager of Affiliate Relations, 215-873-8292, jps@chemheritage.org.

How to listen to JPS recordings:
To listen to past Joseph Priestley Society talks, you may either stream the file or download the file to your computer. If you stream the file, you will be able to begin listening almost immediately and the file will not be stored in the computer's memory. You must remain connected to the Internet while listening to a streaming audio file. If you choose to download the file, the lecture will remain on your computer until you delete it, and you will be able to listen multiple times regardless of whether you are online.

To stream a lecture, click the "Listen Now" link beside the name of the speaker. Your default audio player will open and the talk will begin.

To download a lecture,

1. Right click (on a PC) or control-click (on a Mac) the appropriate "Download mp3" link and select "Save Target As..." or "Download Linked File."
   
   
2. Save the files to a folder on your computer for listening at any time. The file can also be copied to a portable mp3 player.